CG
XBIT icon

Cutler Group’s XBiotech XBIT Stock Holding History

Cutler Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$14K – 4984
2020
Q1 		$14K Buy
+1,000
New +$16.3K ﹤0.01% 2540
2018
Q1 		– Sell
-500
Closed -$1K – 5331
2017
Q4 		$1K Sell
500
-14,700
-97% -$61.9K ﹤0.01% 4624
2017
Q3 		$97K Sell
15,200
-11,400
-43% -$53.8K ﹤0.01% 1696
2017
Q2 		$172K Buy
26,600
+11,800
+80% +$113K 0.01% 1403
2017
Q1 		$42K Buy
14,800
+5,500
+59% +$72K ﹤0.01% 2594
2016
Q4 		$54K Sell
9,300
-7,300
-44% -$97.1K ﹤0.01% 2469
2016
Q3 		$49K Buy
+16,600
New +$244K ﹤0.01% 2500

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cutler Group's XBIT Position: Q2 2020 in Review

Cutler Group sold out of XBiotech (XBIT) in Q2 2020, closing a stake of 2,264 shares — an estimated $31.8K sold.

Cutler Group first reported a position in XBIT in Q3 2016 and held it in 8 quarters. The position peaked at $158K in Q3 2016. 65 funds tracked by Wall St. Rank hold XBIT as of Q2 2020.

  • Cutler Group reported no remaining XBiotech position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 2,264 XBiotech shares in Q2 2020, an estimated $31.8K.
  • Cutler Group first reported a position in XBiotech in Q3 2016 and held it in 8 quarters.
  • Cutler Group's XBiotech position peaked at $158K in Q3 2016.
  • 65 funds tracked by Wall St. Rank held XBiotech as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.